Track Turn Therapeutics's net income ($-8.4M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Loading...
Loading...
As of the most recent data (June 2026), TTRX shows a net income of $-8.4M. That is below the Healthcare sector average of $16B. Scroll down for historical charts and peer comparison views.
The Healthcare sector average net income is about $16B. Turn Therapeutics is at $-8.4M, which is lower that average. That is roughly 100.1% below the sector mean. Use the comparison chart on this page to see how TTRX stacks up against individual peers as well.
Tracking TTRX's net income over time shows whether Turn Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $-8.4M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this net income page, Stockcircle has Turn Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net income (currently $-8.4M) with ownership activity and broader fundamentals.
The Healthcare average net income is about $16B, while TTRX is at $-8.4M. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.